UltraGreen.ai (SGX:ULG) Stock Growth Narrative Meets EPS Reset And Margin Drift

Simply Wall St · 1d ago

UltraGreen.ai walked into this earnings season as a high growth story with strong profit margins and a P/E that looked cheaper than many peers. The stock closed at US$1.32 today, with short term returns still in positive territory. However, the latest half year numbers force investors to question how much of that optimism is already reflected in the price.

The headline this time is margin quality. Net profit margin sits at 41.3%, slightly under last year, which keeps UltraGreen.ai firmly profitable but puts more pressure on management to prove that rich growth expectations can coexist with consistently strong earnings power.

Is UltraGreen.ai genuinely priced like a growth stock, supported by its 41.3% net margin and below-peer P/E, or is the story already fully reflected in the share price? See how the numbers line up in our valuation analysis for UltraGreen.ai

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs H1 2025): US$87.16m vs. US$58.30m (higher period on period)
  • Net Income, excluding extra items (H1 2026 vs H1 2025): US$39.25m vs. US$27.78m (higher period on period)
  • Basic EPS (H1 2026 vs H1 2025): US$0.04 vs. US$56.69 (very large decline)
  • Net Profit Margin (H1 2026 vs prior year): 41.3% vs. 42.5% (slight compression)

Prefer clear charts over scrolling through blocks of earnings tables and raw figures? View a full visual summary of how UltraGreen.ai is currently valued, with key metrics presented in an easy-to-scan dashboard, in our company report for UltraGreen.ai.

SGX:ULG Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SGX:ULG Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

UltraGreen.ai growth story backed by revenue scale

For bullish investors, UltraGreen.ai now has a clearer revenue and profit base to support the integrated surgery platform story. Revenue of US$87.16m and net income of US$39.25m for H1 2026 both sit above the prior period, while net margin holds at a high 41.3%. That combination suggests the hardware, pharma and software mix is at least converting into sizeable earnings, not just promise. Recent positive returns over 7, 30 and 90 days also indicate the market has, so far, treated these numbers as directionally supportive.

UltraGreen.ai risks highlighted by earnings quality signals

The bearish view will lean on earnings quality. Net margin has compressed from 42.5% to 41.3%, which modestly weakens the case that UltraGreen.ai can maintain very high profitability as it scales. Basic EPS of US$0.04 against US$56.69 a year ago is a sharp reset that raises questions about share count, one offs or prior period distortions. Even with higher net income, that kind of EPS move invites scrutiny of capital structure and sustainability of per share economics, especially for investors counting on a clean growth story.

See how UltraGreen.ai's high net margin, EPS reset and recent share price reaction line up with institutional expectations by checking the consensus price target analysis for UltraGreen.ai.

Stay Ahead With Simply Wall St

If UltraGreen.ai's strong net margin, EPS reset and current P/E profile have you watching for a better entry point, register for free with Simply Wall St and add it to a Watchlist to track share price against fair value. When you do decide to take a position, use the Portfolio Command Center to manage your holdings and focus on the most important updates instead of day to day noise. For a broader view on UltraGreen.ai and similar stocks, tap into thousands of investor perspectives through the Community. Catching potential catalysts and risks early can help you stay one step ahead of the market.

Seeking Alternatives Beyond UltraGreen.ai?

Fresh ideas can move fast. Some stocks are building quiet momentum, others are dropping into attractive territory under the radar for now. Check these curated lists and consider them early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.